June 2026 Fresenius Kabi expanded its U.S. injectable medicines portfolio with the introduction of Cyclophosphamide for Injection, strengthening its sterile injectable manufacturing capabilities and reinforcing its commitment to supplying critical hospital medicines across North America.
June 2026 B. Braun Medical increased production capacity for intravenous and electrolyte infusion products across its U.S. manufacturing network to strengthen supply resilience and support growing hospital demand for critical infusion therapies.
May 2025 Baxter restored inventory levels at its Marion, North Carolina manufacturing facility following recovery efforts, strengthening the North American supply of intravenous fluids and electrolyte infusion products for healthcare providers.